Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03145415
Other study ID # lh0001
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date February 17, 2017
Est. completion date December 20, 2019

Study information

Verified date April 2017
Source Nemours Children's Clinic
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of this randomized blinded prospective study is to compare the analgesic efficacy and duration of a Pudendal Nerve Block (PNB) to a Caudal Block (CB) for pediatric patients, ages 6 months to 2 years, undergoing hypospadias repair.


Description:

Hypospadias repair is one of the most common congenital malformations of the penis in the United States. It has an incidence of about 1 in 300 births. A combination of general anesthesia and a caudal block or general anesthesia combined with a pudendal nerve block are commonly used for hypospadias repair. In our institution, hypospadias repair is typically done in infants and children ages 6 months to age two. A comparison of the efficacy of pudendal block versus the caudal block has not been undertaken in this younger population.


Recruitment information / eligibility

Status Completed
Enrollment 60
Est. completion date December 20, 2019
Est. primary completion date December 20, 2019
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Male
Age group 6 Months to 2 Years
Eligibility Inclusion Criteria: - Boys undergoing hypospadias repair Exclusion Criteria: -

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
Caudal block
1 cc per kg of 0.2% ropivicaine in the caudal space given before the start of surgery.
Bilateral Pudendal block
0.5 cc per kg of 0.2% ropivicaine. Half of the volume given as a right pudendal block and the remaining volume given on the left pudendal nerve block given prior to the start of surgery

Locations

Country Name City State
United States Nemours/ duPont Hospital for Children Wilmington Delaware

Sponsors (1)

Lead Sponsor Collaborator
Nemours Children's Clinic

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Opioid consumption The child's care giver will document the times that a rescue opioid was given to relieve pain. up to 24 hours
Secondary Intraoperative block assessment A heart rate increase above of 20 percent of baseline will be an indication of inadequate block that will be treated with a rescue opioid. up to 3 hours
Secondary Post operative pain The FLACC scale scores greater than 6 will be an indication of inadequate pain relief needing a rescue dosages of opioid. up to 2 hours